StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$26.90−0.55 (-2.00%)

Close on Nov 18, 2026Market cap $1.30BP/E –Yield –

Nanobiotix operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -€10.82M. The highest annual figure on record is -€10.82M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€10.82M–
FY2024Dec 31, 2024-€68.39M–
FY2023Dec 31, 2023-€26.78M–
FY2022Dec 31, 2022-€46.70M–
FY2021Dec 31, 2021-€52.58M–
FY2020Dec 31, 2020-€36.43M–
FY2019Dec 31, 2019-€46.78M–
FY2018Dec 31, 2018-€30.07M–

More Nanobiotix figures

See a number that looks wrong?